Granted Patent
B2
US 7,183,381 · App. 11/258,767 · Granted Feb 27, 2007
Composition of lactoferrin related peptides and uses thereof
Assignee:
Agennix, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.
Claims (3)
1. A pharmaceutical composition comprising a lactoferrin related peptide that induces modulation of the immune system whereby the composition stimulates production of macrophage inflammatory protein-3α from hepatoctyes, wherein said lactoferrin related peptide comprises the amino acid sequence of SEQ ID NO:10.
2. An isolated polypeptide having an amino acid sequence as defined in SEQ ID NO:10.
3. The isolated polypeptide of claim 2 , wherein said polypeptide is admixed with a pharmaceutically acceptable carrier.
Assignments (3)
SECURITY AGREEMENT
Recorded Mar 16, 2009
From: AGENNIX INCORPORATED
To: GPC BIOTECH AG
Reel/Frame 022399/0104 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROVISIONAL SERIAL NUMBER FROM 60622172 TO 60622176. PREVIOUSLY RECORDED ON REEL 016999 FRAME 0750. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Recorded Feb 3, 2006
From: VARADHACHARY, ATUL; GLYNN, PETER; PETRAK, KAREL; ENGELMAYER, JOSE
To: AGENNIX INCORPORATED
Reel/Frame 017118/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 11, 2006
From: VARADHACHARY, ATUL; GLYNN, PETER; PETRAK, KAREL; ENGELMAYER, JOSE
To: AGENNIX INCORPORATED
Reel/Frame 016999/0750 →
Continuity (2)
Provisional Application
6062217600
· Oct 26, 2004